Traditional Medicine to Modern Pharmacogenomics: Ayurveda Prakriti Type and CYP2C19 Gene Polymorphism Associated with the Metabolic Variability
2011

Ayurveda Prakriti Type and CYP2C19 Gene Polymorphism

Sample size: 132 publication Evidence: moderate

Author Information

Author(s): Ghodke Yogita, Joshi Kalpana, Patwardhan Bhushan

Primary Institution: University of Pune, India

Hypothesis

Different Prakriti may have different drug metabolism rates associated with drug metabolizing enzyme (DME) polymorphism.

Conclusion

The study found significant associations between CYP2C19 genotypes and Ayurvedic Prakriti types, suggesting metabolic variability based on genetic factors.

Supporting Evidence

  • The extensive metabolizer (EM) genotype was predominant in Pitta Prakriti (91%).
  • Poor metabolizer (PM) genotype was highest in Kapha Prakriti (31%).
  • Genotype specific for EM group was present only in Pitta Prakriti.
  • Genotype typical for PM group was significant in Kapha Prakriti with an odds ratio of 3.5.

Takeaway

This study shows that people with different Ayurvedic body types may process drugs differently because of their genes.

Methodology

CYP2C19 genotyping was performed on 132 healthy subjects using PCR-RFLP technique.

Limitations

The small sample size limits the generalizability of the findings.

Participant Demographics

The study included 132 unrelated healthy subjects (62 males and 70 females) from the Maharashtrian population.

Statistical Information

P-Value

0.008

Statistical Significance

p=0.008

Digital Object Identifier (DOI)

10.1093/ecam/nep206

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication